‹ ›
MYP_013393
← PREVIOUS NEXT → BACK
Basic Information
K10S
Anticancer ▸ Cytotoxic anticancer activity ▸ Cytotoxic
Antimicrobial
Antiviral
Antiviral ▸ Anti-Herpesvirus ▸ Anti-HSV
Antiviral ▸ Antiviral mechanism ▸ Viral replication inhibition
Toxicity / Safety ▸ Cytotoxicity ▸ Cytotoxic
Venom / Toxin ▸ General toxin ▸ Cytotoxic
Standard
10 amino acids
C42H78N12O15S2
Standard
Sequence
KKVTMTCSAS
Physicochemical Analysis
1055.27 Da
9.31
1.75
1.53
0.1748
-0.04
0.20
-0.08
-10.86
39.00
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
458.18
-6.88
18.0
19.0
36.0
71.0
0.0
9.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0008522 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
Coxsackie virus B5:inhibition of viral replication in Vero cells , 94% inhibition at 100 μg/ml
75 %
Inhibition
PaperPubMed PMID: 30654366 PMID30654366 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30654366/
RECORD: Rec_0028862 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-HSV Replication inhibition
HSV-1 | Vero cells
100 μg/mL
% inhibition
Mammalian: 1.3 h; Yeast: 3 min; E. coli: 2 min
PaperAntiviral Activity of Synthetic Peptides Derived from Physiological Proteins. | Sala A, Ardizzoni A, Ciociola T, Magliani W, Conti S, Blasi E, Cermelli C | Intervirology. 2018;61(4):166-173. | DOI:10.1159/000494354 | PMID:30654366 PMID30654366 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30654366/
RECORD: Rec_0041868 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Dermaseptin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
Coxsackievirus B5
PMID30654366 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30654366/
RECORD: Rec_0064555 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Dermaseptin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
Vesicular stomatitis virus
PMID30654366 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30654366/
RECORD: Rec_0122837 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Replication inhibition
Coxsackie virus B5 | Vero cells
100 μg/mL
% inhibition
Mammalian: 1.3 h; Yeast: 3 min; E. coli: 2 min
PaperAntiviral Activity of Synthetic Peptides Derived from Physiological Proteins. | Sala A, Ardizzoni A, Ciociola T, Magliani W, Conti S, Blasi E, Cermelli C | Intervirology. 2018;61(4):166-173. | DOI:10.1159/000494354 | PMID:30654366 PMID30654366 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/30654366/
1 2 3 4 NEXT LAST
Showing 5 records on this page · Page 1 of 4